Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 12/2012

01.12.2012 | Original Paper

Economic factors in of patients’ nonadherence to antidepressant treatment

verfasst von: Haekyung Jeon-Slaughter

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients’ nonadherence to antidepressant treatment hampers cost and efficacy of depression-specific treatment. However, previous studies have failed to find consistent findings in economic effect on nonadherence and also failed to reach consensus in how to measure nonadherence to treatment. The study attempts to investigate income effect on nonadherence to selective serotonin reuptake inhibitors (SSRIs) treatment with clear definitions of nonadherence: self discontinuation of SSRIs (nonpersistence) and under-dose of SSRIs (noncompliance).

Methods

The study extracted data from the National Comorbidity Survey-Replication (NCS-R). The study sample (n = 280) includes adults between the ages of 18 and 64 who were diagnosed with Diagnostic Statistics Manual IV Major Depressive Episode (MDE) at some point during their lifetime and medicated with SSRIs in the past 12 months.

Results

Just above poverty level of family income and no health insurance increased the risk of medication nonpersistence in SSRIs treatment. The study findings confirmed that African Americans were at higher risk of medication noncompliance than Whites (odds ratio, 4.53) and MDE comorbidity was positively associated with medication noncompliance (odds ratio, 4.25).

Conclusions

Low income level, combined with health insurance status, and race/ethnicity, predict nonadherence to antidepressant treatment. The study findings would help physicians and hospitals developing interventional strategies and programs to increase patients’ adherence rates in antidepressant treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Montgomery SA, Kasper S (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 9(Suppl 4):33–40PubMedCrossRef Montgomery SA, Kasper S (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 9(Suppl 4):33–40PubMedCrossRef
6.
Zurück zum Zitat Beasley CM, Koke SC, Nilsson ME, Gonzales JS (2000) Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Clin Ther 22(11):1319–1330. doi:10.1016/s0149-2918(00)83028-3 PubMedCrossRef Beasley CM, Koke SC, Nilsson ME, Gonzales JS (2000) Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Clin Ther 22(11):1319–1330. doi:10.​1016/​s0149-2918(00)83028-3 PubMedCrossRef
7.
Zurück zum Zitat Keller MB, Hirschfeld RMA, Demyttenaere K, Baldwin DS (2002) Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 17(6):265–271PubMedCrossRef Keller MB, Hirschfeld RMA, Demyttenaere K, Baldwin DS (2002) Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol 17(6):265–271PubMedCrossRef
8.
Zurück zum Zitat Chakraborty K, Avasthi A, Kumar S, Grover S (2009) Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment. Soc Psychiatry Psychiatr Epidemiol 44(6):482–488PubMedCrossRef Chakraborty K, Avasthi A, Kumar S, Grover S (2009) Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment. Soc Psychiatry Psychiatr Epidemiol 44(6):482–488PubMedCrossRef
10.
Zurück zum Zitat Masand PS (2003) Tolerability and adherence issues in antidepressant therapy. Clin Ther 25(8):2289–2304PubMedCrossRef Masand PS (2003) Tolerability and adherence issues in antidepressant therapy. Clin Ther 25(8):2289–2304PubMedCrossRef
11.
Zurück zum Zitat DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRef DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRef
12.
13.
Zurück zum Zitat Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET (2005) Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry 66:220–227PubMedCrossRef Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET (2005) Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry 66:220–227PubMedCrossRef
14.
Zurück zum Zitat Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC (2006) Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 44(4):300–303PubMedCrossRef Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC (2006) Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 44(4):300–303PubMedCrossRef
15.
16.
Zurück zum Zitat Sawada N, Uchida H, Suzuki T, Watanabe K, Kikuchi T, Handa T, Kashima H (2009) Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry 9:38. doi:10.1186/1471-244X-9-38 PubMedCrossRef Sawada N, Uchida H, Suzuki T, Watanabe K, Kikuchi T, Handa T, Kashima H (2009) Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry 9:38. doi:10.​1186/​1471-244X-9-38 PubMedCrossRef
20.
Zurück zum Zitat McHorney CA, Spain VC, Alexander CM, Simmons J (2009) Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clin Ther 31(11):2584–2607. doi:10.1016/j.clinthera.2009.11.030 PubMedCrossRef McHorney CA, Spain VC, Alexander CM, Simmons J (2009) Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clin Ther 31(11):2584–2607. doi:10.​1016/​j.​clinthera.​2009.​11.​030 PubMedCrossRef
21.
Zurück zum Zitat Claesson S, Morrison A, Wertheimer AI, Berger ML (1999) Compliance with prescribed drugs: challenges for the elderly population. Pharm World Sci 21(6):256–259PubMedCrossRef Claesson S, Morrison A, Wertheimer AI, Berger ML (1999) Compliance with prescribed drugs: challenges for the elderly population. Pharm World Sci 21(6):256–259PubMedCrossRef
24.
Zurück zum Zitat Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL (2009) Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 43(1):36–44. doi:10.1345/aph.1K671 PubMedCrossRef Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL (2009) Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 43(1):36–44. doi:10.​1345/​aph.​1K671 PubMedCrossRef
25.
Zurück zum Zitat Hess LM, Raebel MA, Conner DA, Malone DC (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 40(7):1280–1288. doi:10.1345/aph.1H018 PubMedCrossRef Hess LM, Raebel MA, Conner DA, Malone DC (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 40(7):1280–1288. doi:10.​1345/​aph.​1H018 PubMedCrossRef
26.
Zurück zum Zitat Demyttenaere K (1998) Noncompliance with antidepressants: who’s to blame? Int Clin Psychopharmacol 13(Suppl. 2):S19–S25PubMedCrossRef Demyttenaere K (1998) Noncompliance with antidepressants: who’s to blame? Int Clin Psychopharmacol 13(Suppl. 2):S19–S25PubMedCrossRef
28.
Zurück zum Zitat Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Raue P, Friedman SJ, Meyers BS (2001) Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 158(3):479–481. doi:10.1176/appi.ajp.158.3.479 PubMedCrossRef Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Raue P, Friedman SJ, Meyers BS (2001) Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 158(3):479–481. doi:10.​1176/​appi.​ajp.​158.​3.​479 PubMedCrossRef
29.
Zurück zum Zitat Demyttenaere K, Enzlin P, Dewé W, Boulanger B, De Bie J, De Troyer W, Mesters P (2001) Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62(Suppl 22):30–33PubMed Demyttenaere K, Enzlin P, Dewé W, Boulanger B, De Bie J, De Troyer W, Mesters P (2001) Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62(Suppl 22):30–33PubMed
30.
Zurück zum Zitat Bosworth HB, Voils CI, Potter GG, Steffens DC (2008) The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. Int J Geriatr Psychiatry 23(2):129–134. doi:10.1002/gps.1852 PubMedCrossRef Bosworth HB, Voils CI, Potter GG, Steffens DC (2008) The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. Int J Geriatr Psychiatry 23(2):129–134. doi:10.​1002/​gps.​1852 PubMedCrossRef
31.
Zurück zum Zitat Sawamura K, Ito H, Koyama A, Tajima M, Higuchi T (2010) The effect of an educational leaflet on depressive patients’ attitudes toward treatment. Psychiatry Res 177(1–2):184–187PubMedCrossRef Sawamura K, Ito H, Koyama A, Tajima M, Higuchi T (2010) The effect of an educational leaflet on depressive patients’ attitudes toward treatment. Psychiatry Res 177(1–2):184–187PubMedCrossRef
32.
Zurück zum Zitat Shelton C (2009) Factors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherence. CNS Spectr 14(suppl 12):15–19PubMed Shelton C (2009) Factors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherence. CNS Spectr 14(suppl 12):15–19PubMed
36.
37.
Zurück zum Zitat Dobscha S, Winterbottom L, Snodgrass L (2007) Reducing drug costs at a veterans affairs hospital by increasing market-share of generic fluoxetine. Community Ment Health J 43(1):75–84PubMedCrossRef Dobscha S, Winterbottom L, Snodgrass L (2007) Reducing drug costs at a veterans affairs hospital by increasing market-share of generic fluoxetine. Community Ment Health J 43(1):75–84PubMedCrossRef
38.
Zurück zum Zitat Fischer JF, Mowers RM, Ormerod DJ, Burris ES (2001) Driving market share in an integrated health system without therapeutic interchange. J Manag Care Pharm 7(4):283–286 Fischer JF, Mowers RM, Ormerod DJ, Burris ES (2001) Driving market share in an integrated health system without therapeutic interchange. J Manag Care Pharm 7(4):283–286
39.
Zurück zum Zitat Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of mental health services in the United States: results from the national comorbidity survey replication. Arch Gen Psychiatry 62(6):624–629 Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005) Twelve-month use of mental health services in the United States: results from the national comorbidity survey replication. Arch Gen Psychiatry 62(6):624–629
40.
41.
Zurück zum Zitat Burra TA, Chen E, McIntyre RS, Grace SL, Blackmore ER, Stewart DE (2007) Predictors of self-reported antidepressant adherence. Behav Med 32(4):127–134PubMedCrossRef Burra TA, Chen E, McIntyre RS, Grace SL, Blackmore ER, Stewart DE (2007) Predictors of self-reported antidepressant adherence. Behav Med 32(4):127–134PubMedCrossRef
42.
Zurück zum Zitat Brook OH, van Hout HPJ, Stalman WAB, de Haan M (2006) Nontricyclic antidepressants: predictors of nonadherence. J Clin Psychopharmacol 26(6):643–647PubMed Brook OH, van Hout HPJ, Stalman WAB, de Haan M (2006) Nontricyclic antidepressants: predictors of nonadherence. J Clin Psychopharmacol 26(6):643–647PubMed
43.
Zurück zum Zitat Proctor BD, Dalaker J (2002) Current population reports. In: Poverty in the united states: 2001. US Government Printing Office, Washington, DC Proctor BD, Dalaker J (2002) Current population reports. In: Poverty in the united states: 2001. US Government Printing Office, Washington, DC
44.
Zurück zum Zitat Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM (2005) Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 352(24):2515–2523PubMedCrossRef Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM (2005) Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 352(24):2515–2523PubMedCrossRef
45.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder: results from the national comorbidity survey replication (ncs-r). JAMA 289(23):3095–3105. doi:10.1001/jama.289.23.3095 PubMedCrossRef Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder: results from the national comorbidity survey replication (ncs-r). JAMA 289(23):3095–3105. doi:10.​1001/​jama.​289.​23.​3095 PubMedCrossRef
46.
Zurück zum Zitat American Psychiatric Association (2000) Practice guideline for the treatment of patients with major depression. American Psychiatric Association, Arlington American Psychiatric Association (2000) Practice guideline for the treatment of patients with major depression. American Psychiatric Association, Arlington
47.
Zurück zum Zitat Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW (2006) Higher costs and therapeutic factors associated with adherence to ncqa hedis antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharmacy 12(1):43–54 Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW (2006) Higher costs and therapeutic factors associated with adherence to ncqa hedis antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharmacy 12(1):43–54
48.
Zurück zum Zitat Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M (2006) Bupropion-sr, sertraline, or venlafaxine-xr after failure of ssris for depression. N Engl J Med 354(12):1231–1242. doi:10.1056/NEJMoa052963 PubMedCrossRef Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M (2006) Bupropion-sr, sertraline, or venlafaxine-xr after failure of ssris for depression. N Engl J Med 354(12):1231–1242. doi:10.​1056/​NEJMoa052963 PubMedCrossRef
49.
Zurück zum Zitat Kocsis JH, Schatzberg A, Rush AJ, Klein DN, Howland R, Gniwesch L, Davis SM, Harrison W (2002) Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. Arch Gen Psychiatry 59(8):723–728. doi:10.1001/archpsyc.59.8.723 PubMedCrossRef Kocsis JH, Schatzberg A, Rush AJ, Klein DN, Howland R, Gniwesch L, Davis SM, Harrison W (2002) Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. Arch Gen Psychiatry 59(8):723–728. doi:10.​1001/​archpsyc.​59.​8.​723 PubMedCrossRef
50.
Zurück zum Zitat Keller MB, Kocsis JH, Thase ME, Gelenberg AJ, Rush AJ, Koran L, Schatzberg A, Russell J, Hirschfeld R, Klein D, McCullough JP, Fawcett JA, Kornstein S, LaVange L, Harrison W, For the Sertraline Chronic Depression Study Group (1998) Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 280(19):1665–1672. doi:10.1001/jama.280.19.1665 PubMedCrossRef Keller MB, Kocsis JH, Thase ME, Gelenberg AJ, Rush AJ, Koran L, Schatzberg A, Russell J, Hirschfeld R, Klein D, McCullough JP, Fawcett JA, Kornstein S, LaVange L, Harrison W, For the Sertraline Chronic Depression Study Group (1998) Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 280(19):1665–1672. doi:10.​1001/​jama.​280.​19.​1665 PubMedCrossRef
51.
Zurück zum Zitat Terra JL, Montgomery SA (1998) Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharmacol 13(2):55–62PubMedCrossRef Terra JL, Montgomery SA (1998) Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharmacol 13(2):55–62PubMedCrossRef
52.
Zurück zum Zitat RTI International-University of North Carolina Evidence-based Practice Center (2007) Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression: comparative effectiveness review. Agency for Healthcare Research and Quality, Rockville RTI International-University of North Carolina Evidence-based Practice Center (2007) Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression: comparative effectiveness review. Agency for Healthcare Research and Quality, Rockville
53.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of dsm-iv disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):593–602. doi:10.1001/archpsyc.62.6.593 PubMedCrossRef Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of dsm-iv disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):593–602. doi:10.​1001/​archpsyc.​62.​6.​593 PubMedCrossRef
54.
Zurück zum Zitat Fleck DE, Hendricks WL, DelBello MP, Strakowski SM (2002) Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder. J Clin Psychiatry 63(8):658–664PubMedCrossRef Fleck DE, Hendricks WL, DelBello MP, Strakowski SM (2002) Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder. J Clin Psychiatry 63(8):658–664PubMedCrossRef
55.
Zurück zum Zitat Diaz E, Woods SW, Rosenheck RA (2005) Effects of ethnicity on psychotropic medications adherence. Community Ment Health J 41(5):521–537PubMedCrossRef Diaz E, Woods SW, Rosenheck RA (2005) Effects of ethnicity on psychotropic medications adherence. Community Ment Health J 41(5):521–537PubMedCrossRef
56.
Zurück zum Zitat Wu C-H, Erickson SR, Piette JD, Balkrishnan R. The association of race, comorbid anxiety, and antidepressant adherence among medicaid enrollees with major depressive disorder. ResSoc Adm Pharmacy. doi:10.1016/j.sapharm.2011.04.002 Wu C-H, Erickson SR, Piette JD, Balkrishnan R. The association of race, comorbid anxiety, and antidepressant adherence among medicaid enrollees with major depressive disorder. ResSoc Adm Pharmacy. doi:10.​1016/​j.​sapharm.​2011.​04.​002
58.
Zurück zum Zitat Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR (2003) Race and trust in the health care system. Public Health Rep 118(4):358–365PubMed Boulware LE, Cooper LA, Ratner LE, LaVeist TA, Powe NR (2003) Race and trust in the health care system. Public Health Rep 118(4):358–365PubMed
60.
Zurück zum Zitat Chakraborty A, King M, Leavey G, McKenzie K (2011) Perceived racism, medication adherence, and hospital admission in african-caribbean patients with psychosis in the United Kingdom. Soc Psychiatry Psychiatr Epidemiol 46(9):915–923. doi:10.1007/s00127-010-0261-8 PubMedCrossRef Chakraborty A, King M, Leavey G, McKenzie K (2011) Perceived racism, medication adherence, and hospital admission in african-caribbean patients with psychosis in the United Kingdom. Soc Psychiatry Psychiatr Epidemiol 46(9):915–923. doi:10.​1007/​s00127-010-0261-8 PubMedCrossRef
61.
Zurück zum Zitat Fleck DE, Keck PE, Corey KB, Strakowski SM (2005) Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry 63(8):658–664CrossRef Fleck DE, Keck PE, Corey KB, Strakowski SM (2005) Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry 63(8):658–664CrossRef
62.
Zurück zum Zitat Papakostas GI (2009) Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 70(Suppl 6):16–25PubMedCrossRef Papakostas GI (2009) Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 70(Suppl 6):16–25PubMedCrossRef
63.
Zurück zum Zitat Thacher JA, Morey E, Craighead WE (2005) Using patient characteristics and attitudinal data to identify depression treatment preference groups: a latent-class model. Depression Anxiety 21(2):47–54CrossRef Thacher JA, Morey E, Craighead WE (2005) Using patient characteristics and attitudinal data to identify depression treatment preference groups: a latent-class model. Depression Anxiety 21(2):47–54CrossRef
65.
66.
Zurück zum Zitat Masand PS, Roca M, Turner MS, Kane JM (2009) Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 11(4):147–154PubMedCrossRef Masand PS, Roca M, Turner MS, Kane JM (2009) Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review. Prim Care Companion J Clin Psychiatry 11(4):147–154PubMedCrossRef
67.
Zurück zum Zitat McLaughlin T, Hogue SL, Stang PE (2007) Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression. American J Therapeutics 14 (2):221-225 210.1097/1001.mjt.0000208273.0000280496.0000208273f McLaughlin T, Hogue SL, Stang PE (2007) Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression. American J Therapeutics 14 (2):221-225 210.1097/1001.mjt.0000208273.0000280496.0000208273f
68.
Zurück zum Zitat Croghan TW, Melfi CA, Dobrez DG, Kniesner TJ (1999) Effect of mental health specialty care on antidepressant length of therapy. Medical Care 37(Suppl 4):AS20–AS23PubMedCrossRef Croghan TW, Melfi CA, Dobrez DG, Kniesner TJ (1999) Effect of mental health specialty care on antidepressant length of therapy. Medical Care 37(Suppl 4):AS20–AS23PubMedCrossRef
69.
Zurück zum Zitat Van Voorhees BW, Cooper LA, Rost KM, Nutting P, Rubenstein LV, Meredith L, Wang NY, Ford DE (2003) Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med 18(12):991–1000PubMedCrossRef Van Voorhees BW, Cooper LA, Rost KM, Nutting P, Rubenstein LV, Meredith L, Wang NY, Ford DE (2003) Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med 18(12):991–1000PubMedCrossRef
72.
Zurück zum Zitat Tamburrino MB, Nagel RW, Chahal MK, Lynch DJ (2009) Antidepressant medication adherence: a study of primary care patients. J Clin Psychiatry 11(5):205–211 Tamburrino MB, Nagel RW, Chahal MK, Lynch DJ (2009) Antidepressant medication adherence: a study of primary care patients. J Clin Psychiatry 11(5):205–211
73.
Zurück zum Zitat Demyttenaere K, Enzlin P, Dewé W, Boulanger B, De Bie J, De Troyer W, Mesters P (2001) Compliance with antidepressants in a primary care setting, 2: influence of gender and types of impairment. J Clin Psychiatry 62(Suppl 22):34–37PubMed Demyttenaere K, Enzlin P, Dewé W, Boulanger B, De Bie J, De Troyer W, Mesters P (2001) Compliance with antidepressants in a primary care setting, 2: influence of gender and types of impairment. J Clin Psychiatry 62(Suppl 22):34–37PubMed
74.
Zurück zum Zitat Shigemura J, Ogawa T, Yoshino A, Sato Y, Nomura S (2010) Predictors of antidepressant adherence: results of a Japanese internet-based survey. Psychiatry Clin Neurosci 64:179–186PubMedCrossRef Shigemura J, Ogawa T, Yoshino A, Sato Y, Nomura S (2010) Predictors of antidepressant adherence: results of a Japanese internet-based survey. Psychiatry Clin Neurosci 64:179–186PubMedCrossRef
75.
Zurück zum Zitat Lee M-S, Lee H-Y, Kang S-G, Yang J, Ahn H, Rhee M, Ko Y-H, Joe S-H, Jung I-K, Kim S-H (2010) Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord 123(1–3):216–221PubMedCrossRef Lee M-S, Lee H-Y, Kang S-G, Yang J, Ahn H, Rhee M, Ko Y-H, Joe S-H, Jung I-K, Kim S-H (2010) Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord 123(1–3):216–221PubMedCrossRef
76.
Zurück zum Zitat Kobak KA, Taylor L, Katzelnick DJ, Olson N, Clagnaz P, Henk HJ (2002) Antidepressant medication management and health plan employer data information set (hedis) criteria: reasons for nonadherence. J Clin Psychiatry 63(8):727–732PubMedCrossRef Kobak KA, Taylor L, Katzelnick DJ, Olson N, Clagnaz P, Henk HJ (2002) Antidepressant medication management and health plan employer data information set (hedis) criteria: reasons for nonadherence. J Clin Psychiatry 63(8):727–732PubMedCrossRef
77.
Zurück zum Zitat Lin EH, Von Korff M, Katon W, Bush T, Simon GE, Walker E, Robinson P (1995) The role of the primary care physician in patients’ adherence to antidepressant therapy. Med Care 33(1):67–74PubMedCrossRef Lin EH, Von Korff M, Katon W, Bush T, Simon GE, Walker E, Robinson P (1995) The role of the primary care physician in patients’ adherence to antidepressant therapy. Med Care 33(1):67–74PubMedCrossRef
78.
Zurück zum Zitat van Geffen E, van der Wal S, van Hulten R, de Groot M, Egberts A, Heerdink E (2007) Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system. Eur J Clin Pharmacol 63(12):1193–1199PubMedCrossRef van Geffen E, van der Wal S, van Hulten R, de Groot M, Egberts A, Heerdink E (2007) Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system. Eur J Clin Pharmacol 63(12):1193–1199PubMedCrossRef
79.
Zurück zum Zitat Demyttenaere K (1997) Compliance during treatment with antidepressants. J Affect Disord 43(1):27–39PubMedCrossRef Demyttenaere K (1997) Compliance during treatment with antidepressants. J Affect Disord 43(1):27–39PubMedCrossRef
Metadaten
Titel
Economic factors in of patients’ nonadherence to antidepressant treatment
verfasst von
Haekyung Jeon-Slaughter
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 12/2012
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-012-0497-6

Weitere Artikel der Ausgabe 12/2012

Social Psychiatry and Psychiatric Epidemiology 12/2012 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.